Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01981252 · ClinicalTrials.gov registry record · NA
Peri-orbital and Peri-oral Wrinkle Reduction Trial
A NA study, sponsored by Ulthera.
- Terminated
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01981252 is a NA study that was terminated before completion, run by Ulthera. The registered enrollment target is 90 participants.
The verdict
NCT01981252, a NA study, was terminated before completion, sponsored by Ulthera.
- TERMINATED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This is prospective, multi-center, single-blinded, non-randomized clinical trial. Enrolled subjects will receive two Ulthera® treatments on the peri-orbital and peri-oral regions, each treatment provided 30 days apart. Follow-up visits will occur at 90 and 180 days following treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.
Interventions
- DEVICE Ulthera® System Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01981252
The ClinicalTrials.gov registry entry for NCT01981252 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ulthera® System Treatment is the first listed.
NCT01981252 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01981252 about?
NCT01981252 is a clinical study titled "Peri-orbital and Peri-oral Wrinkle Reduction Trial". This is prospective, multi-center, single-blinded, non-randomized clinical trial. Enrolled subjects will receive two Ulthera® treatments on the peri-orbital and peri-oral regions, each treatment provided 30 days apart. Follow-up visits will occur at 90 and 180 days following treatment. Study images ...
What is the current status of trial NCT01981252?
This trial is currently terminated. It is a NA study. The enrollment target is 90 participants. The study started on 2013-10. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01981252?
The interventions under investigation include: Ulthera® System Treatment (DEVICE).
Who is sponsoring clinical trial NCT01981252?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.